Nurix Therapeutics Overview
Nurix Therapeutics Target Price
Analysts' 12-month price predictions for NRIX.
Share Price
$9.5
Average Target Price
$16.50
73.7% upside
73.7% upside2 analysts in the last 4 months
High: $17 | Low: $16
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-17 | Leerink Partners | $16 | 68.4% upside |  |
| 2025-02-03 | Morgan StanleyTerence Flynn | $17 | 78.9% upside | |
| 2024-12-05 | BMO CapitalEtzer Darout | $35 | 268.4% upside | |
| 2024-10-24 | UBSDavid Dai | $35 | 268.4% upside | |
| 2024-10-21 | H.C. WainwrightRobert Burns | $30 | 215.8% upside | |
| 2024-10-15 | OppenheimerMatthew Biegler | $35 | 268.4% upside | |
| 2024-10-15 | Wells FargoDerek Archila | $32 | 236.8% upside | |
| 2024-10-14 | Stifel NicolausStephen Willey | $34 | 257.9% upside | |
| 2024-10-11 | JefferiesRoger Song | $41 | 331.6% upside | |
| 2024-09-05 | Robert W. BairdBrian Skorney | $26 | 173.7% upside | |
| 2024-08-14 | OppenheimerMatthew Biegler | $27 | 184.2% upside | |
| 2024-06-27 | RBC CapitalGregory Renza | $26 | 173.7% upside | |
| 2024-06-18 | H.C. WainwrightRobert Burns | $26 | 173.7% upside | |
| 2024-06-05 | Piper SandlerTyler Van Buren | $35 | 268.4% upside | |
| 2024-04-11 | RBC CapitalGregory Renza | $23 | 142.1% upside | |
| 2024-04-11 | Robert W. BairdJoel Beatty | $25 | 163.2% upside | |
| 2022-12-13 | Leerink Partners | $28 | 194.7% upside | |
| 2022-05-31 | Wells FargoDerek Archila | $25 | 163.2% upside | |